Differences between antipsychotic drugs in persistence of brain levels and behavioral effects
- 1 August 1992
- journal article
- Published by Springer Nature in Psychopharmacology
- Vol. 108 (3), 338-344
- https://doi.org/10.1007/bf02245121
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockadeBrain Research, 1987
- In Vivo Assay for Neuroleptic Receptor Binding in the StriatumThe British Journal of Psychiatry, 1987
- Persistence of Plasma Neuroleptic Levels after Drug DiscontinuationJournal of Clinical Psychopharmacology, 1987
- Blood to brain distribution of neurolepticsPsychiatry Research, 1987
- Review of Haloperidol Blood Level and Clinical ResponseJournal of Clinical Psychopharmacology, 1987
- Behavioral effects of a single neuroleptic treatment grow with the passage of timeBrain Research, 1986
- Behavioral effects of (−)10, 11-methylenedioxy-n-n-propylnoraporphined, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphinesNeuropharmacology, 1982
- Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the ratLife Sciences, 1980
- Chlorpromazine Metabolism in Chronic SchizophrenicsThe British Journal of Psychiatry, 1971
- Further studies of chlorpromazine metabolism and relapse rateJournal of Psychiatric Research, 1965